121 Aufrufe 121 0 Kommentare 0 Kommentare

    Kenvue, Maker of Neutrogena(R), Aveeno(R), OGX(R), and Zyrtec(R), Beats 2025 Packaging Goal, Demonstrates Continued Progress With More Sustainable Innovation

    Annual report offers details of how Kenvue is delivering its Healthy Lives Mission with a focus on enabling healthier outcomes for people and the planet. NORTHAMPTON, MA / ACCESS Newswire / June 16, 2026 / Kenvue released its 2025 Healthy Lives …

    Kenvue, Maker of Neutrogena(R), Aveeno(R), OGX(R), and Zyrtec(R), Beats 2025 Packaging Goal, Demonstrates Continued Progress With More Sustainable Innovation

    Annual report offers details of how Kenvue is delivering its Healthy Lives Mission with a focus on enabling healthier outcomes for people and the planet.

    NORTHAMPTON, MA / ACCESS Newswire / June 16, 2026 / Kenvue released its 2025 Healthy Lives Mission Report today, the Company's third annual report, with an update on its sustainability strategy, goals, and commitments. With its Healthy Lives Mission designed to put the extraordinary power of everyday care into action, the consumer health company reported progress across its focus on healthy people, healthy planet, and healthy products.

    Through targeted efforts across product innovation, packaging solutions, public health and environmental stewardship, Kenvue reported disciplined progress across its commitments, including:

    • $50.0M of in-kind donations and $3.4M of cash contributions provided across the year, helping restore the dignity of everyday care for vulnerable and displaced people around the world.

    • 450,000 students and 18,000 teachers educated on sun safety and skin cancer prevention.

    • 41% reduction in Scopes 1 and 2GHG emissions from a 2020 base year, putting the company well on track to meet a 2030 goal of 42% reduction, aligned with its Climate Transition Plan, released this year as part of its annual report.

    • 76% electricity now sourced from renewable sources across global Kenvue operations, on its way to meet a goal of 100% by 2030.

    • Continued reduction of virgin plastics by 33%from a 2020 base year, exceeding its goal of reducing 25% by 2025.

    • 600+ product developers trained on the Sustainable Innovation Profiler, a patent-pending product sustainability assessment tool released in 2025, which helps measure and improve product performance for social and environmental factors.

    As a dedicated consumer health company, Kenvue is people-centered and science-backed: improving quality of life today while ensuring a healthier, more resilient world for generations to come. Learn more here.

    +++

    Media Contact
    Aman Singh
    ASing030@kenvue.com

    Find more stories and multimedia from Kenvue at 3blmedia.com.

    Contact Info:
    Spokesperson: Kenvue
    Website: https://www.3blmedia.com/profiles/kenvue
    Email: info@3blmedia.com

    SOURCE: Kenvue



    View the original press release on ACCESS Newswire


    The Kenvue Stock at the time of publication of the news with a raise of +0,22 % to 15,79EUR on Tradegate stock exchange (16. Juni 2026, 14:06 Uhr).




    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We are ACCESS Newswire, a globally trusted Public Relations (PR) and Investor Relations (IR) solutions provider. With a focus on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands to connect with their audiences where it matters most. From startups and scale-ups to multi-billion-dollar global brands, we ensure your most important moments make an impact and resonate with your audiences.
    Mehr anzeigen

    Verfasst von Accesswire
    Kenvue, Maker of Neutrogena(R), Aveeno(R), OGX(R), and Zyrtec(R), Beats 2025 Packaging Goal, Demonstrates Continued Progress With More Sustainable Innovation Annual report offers details of how Kenvue is delivering its Healthy Lives Mission with a focus on enabling healthier outcomes for people and the planet. NORTHAMPTON, MA / ACCESS Newswire / June 16, 2026 / Kenvue released its 2025 Healthy Lives …

    Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.
    Profitieren Sie von unserem Alleinstellungsmerkmal als den zentralen verlagsunabhängigen Wissens-Hub für einen aktuellen und fundierten Zugang in die Börsen- und Wirtschaftswelt, um strategische Entscheidungen zu treffen.
    • ✅ Größte Finanz-Community Deutschlands
    • ✅ über 550.000 registrierte Nutzer
    • ✅ rund 2.000 Beiträge pro Tag
    • ✅ verlagsunabhängige Partner ARIVA, FinanzNachrichten und BörsenNews
    • ✅ Jederzeit einfach handeln beim SMARTBROKER+
    • ✅ mehr als 25 Jahre Marktpräsenz
    Aktien von A - Z: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    wallstreetONLINE bei X wallstreetONLINE bei Instagram wallstreetONLINE bei Facebook wallstreetONLINE bei Youtube wallstreetONLINE bei LinkedIn
    Unsere Apps: Apple App Store Icon Google Play Store Icon
    Wenn Sie Kursdaten, Widgets oder andere Finanzinformationen benötigen, hilft Ihnen ARIVA gerne. 

    Unsere User schätzen wallstreet-online.de: 4.8 von 5 Sternen ermittelt aus 285 Bewertungen bei www.kagels-trading.de
    Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min. NASDAQ +15 Min. NYSE +20 Min. AMEX +20 Min. Dow Jones +15 Min. Alle Angaben ohne Gewähr.
    Copyright © 1998-2026 Smartbroker Holding AG - Alle Rechte vorbehalten.
    Mit Unterstützung von: Ariva Smartbroker+
    Daten & Kurse von: TTMzero